HLA-B*14:02-Restricted Env-Specific CD8<sup>+</sup> T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection.

J Virol · 2017 · PMC5660483 · PMID 28878089

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

4A ), K588Q is strongly selected among both HLA-B*14:01- and HLA-B*14:02-positive persons, and variants at Env-588 and at other residues within Env-EL9 are observed more commonly in HLA-B*14:02-positive subjects (although here these differences between HLA-B*14:01 and HLA-B*14:02 did not reach statistical significance) ( Fig. 4B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

HLA-B*14:02-Restricted Env-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection.

The sentences

HLA-B*14:02-Restricted Env-Specific CD8<sup>+</sup> T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection.